Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 1 of 93 PageID #: 2816
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`
`WILLOW INNOVATIONS, INC.,
`
` Plaintiff and Counterclaim Defendant,
`
`
`
`CHIARO TECHNOLOGY, LTD.,
`
` Defendant and Counterclaim Plaintiff.
`
`
`v.
`
`
`
`
`
`
`
`Civil Action No. 2:23-cv-00229
`
`JURY TRIAL DEMANDED
`
`
`
`
`
`
`CHIARO TECHNOLOGY, LTD.’S ANSWER TO PLAINTIFF’S FIRST AMENDED
`COMPLAINT AND SECOND AMENDED COUNTERCLAIMS
`
`Defendant/Counterclaim Plaintiff Chiaro Technology Ltd. (“Defendant” or “Elvie”)
`
`hereby submits its Answer, Defenses, and Counterclaims to Plaintiff’s First Amended Complaint
`
`for Patent Infringement (“Complaint”) filed by Willow Innovations, Inc. (“Willow” or
`
`“Plaintiff”). Any and all allegations contained in Plaintiff’s Complaint not expressly admitted in
`
`this Answer are denied.
`
`GENERAL DENIAL
`
`Elvie denies all allegations in Plaintiff’s Complaint except for those specifically admitted
`
`below. With respect to the allegations made in the Complaint, upon knowledge with respect to
`
`Elvie’s own acts, and upon information and belief as to other matters, Elvie responds and alleges
`
`as follows:
`
`1.
`
`Plaintiff Willow Innovations, Incorporated is a corporation organized and existing
`
`THE PARTIES
`
`
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 2 of 93 PageID #: 2817
`
`
`under the laws of the State of Delaware, having a principal place of business at 1975 El Camino
`Real, Suite 306, Mountain View, CA 94040. On October 21, 2020, Willow changed its name
`from “Exploramed NC7, Inc.” to “Willow Innovations, Inc.”
`
`ANSWER: Elvie lacks sufficient knowledge and information to form a belief as to the
`
`truth of the allegations of Paragraph 1 as pled and denies those allegations on that basis.
`
`2.
`Defendant Chiaro Technology, Limited is a corporation organized and existing
`under the laws of the United Kingdom, with its principal place of business at 63-66 Hatton
`Garden, EC1N 8LE, London, United Kingdom. On the information and belief, Elvie is the
`trading name of Chiaro Technology Limited and conducts business, either directly or through its
`agents, on an ongoing basis in this judicial district and elsewhere in the United States.
`
`ANSWER: Elvie admits that Chiaro Technology, Limited is a corporation organized
`
`and existing under the laws of England and Wales, with its principal place of business at 63-66
`
`Hatton Garden, EC1N 8LE, London, United Kingdom. Elvie further admits that Elvie is the
`
`trading name of Chiaro Technology Limited. Elvie denies the remaining allegations of Paragraph
`
`2.
`
`BACKGROUND
`
`3.
`Traditional breast milk pumps were decades overdue for innovation. Enter the
`Willow Pump. Founded in 2014, Willow revolutionized the way women pump with the world’s
`first spillproof, in-bra wearable breast pump. Selected as one of TIME Magazine’s 25 Best
`Inventions, the Willow pump was the first to get rid of the heavy motors, tubes, and electrical
`cords—and put moms in control. Traditional pumps required nursing moms to sacrifice hours of
`their day connected to an electrical outlet or to a heavy, conspicuous appliance. Pumping in
`public required either exposing a breast in public, or relying on a public bathroom or similarly
`inconvenient location. Willow was the first to make it possible to pump anywhere, giving moms
`back their privacy, dignity, and freedom of movement. Since then, Willow has grown into a
`market leader, providing moms with industry-leading suction technology. Willow has gradually
`grown its array of product offerings, with a primary focus on the U.S.—the world’s largest
`market for breast pumps.
`
`ANSWER: Paragraph 3 of the Complaint contains statements that are neither
`
`allegations nor averments to which a response is required. To the extent a response is required,
`
`Elvie lacks sufficient knowledge and information to form a belief as to the truth of the
`
`allegations of Paragraph 3 as pled and denies those allegations on that basis.
`
`
`
`2
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 3 of 93 PageID #: 2818
`
`
`4.
`Also in 2014, Willow filed for its first United States patent application. It now
`holds more than 35 issued U.S. patents covering the functionality and designs of its products,
`with additional applications currently pending before the United States Patent Office
`(“USPTO”). In addition, Willow holds dozens of international patents in jurisdictions such as
`Australia, Singapore, China, Europe, Japan, Korea, Hong Kong, and the United Kingdom. To
`protect its hard-earned innovations, Willow provides notice to prospective infringers of its
`extensive patent portfolio via its website. https://onewillow.com/about-willow/patents/. This
`publication also satisfies the standard for constructive notice under 35 U.S.C. § 287(a) for
`purposes of virtual patent marking.
`
`ANSWER: Paragraph 4 contains legal conclusions and allegations to which no
`
`response is required. To the extent a response is required, Elvie denies that Willow’s virtual
`
`patent marking provides sufficient notice to the public of each patent covering each of Willow’s
`
`products. Elvie otherwise lacks sufficient knowledge and information to form a belief as to the
`
`truth of the allegations of Paragraph 4 as pled and denies those allegations on that basis.
`
`5.
`Today, Willow is a market leader in “femtech”—a shorthand term used to
`describe technology products and services that support women’s health. The femtech industry is
`projected to be worth $50 billion by 2025. Willow’s product offerings include wearable pumps,
`containers, pumping bras, carrying bags, and other accessories. https://onewillow.com/#. Willow
`offers for sale these products via its website and through select retailers and online marketplaces,
`such as Target, Best Buy, buybuy Baby, and Amazon.
`
`ANSWER: Paragraph 5 of the Complaint contains statements that are neither
`
`allegations nor averments to which a response is required. To the extent a response is required,
`
`Elvie lacks sufficient knowledge and information to form a belief as to the truth of the
`
`allegations of Paragraph 5 as pled and denies those allegations on that basis.
`
`6.
`Elvie is based in the United Kingdom and launched its Elvie Pump system in
`2018 at the London Fashion Week. https://techcrunch.com/2018/09/14/kegel-trainer-startup-
`elvie-is- launching-a-smaller-smarter-breast-pump/. Later that year, Elvie received clearance
`from the U.S. Food and Drug Administration to market the Elvie Pump in the U.S.
`https://www.accessdata.fda.gov/cdrh_docs/pdf18/K181863.pdf. In its pre-market notification
`report submitted to the FDA, Elvie admitted that its breast pump is substantially equivalent to the
`Willow Pump. See id. (citing product code “HGX” to show the Willow Pump was an FDA-
`cleared predicate device to the Elvie Pump).
`
`ANSWER: Elvie admits that it has its principal place of business in the United
`
`Kingdom. Elvie admits that it received clearance from the U.S. Food and Drug Administration to
`
`
`
`3
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 4 of 93 PageID #: 2819
`
`
`market the Elvie Pump in the United States and released its Pump system during the 2018
`
`London Fashion Week. Elvie also states that the Medela Freestyle is the predicate device that is
`
`listed in the Elvie Pump 510(k) premarket notification. Elvie denies the remaining allegations of
`
`Paragraph 6.
`
`7.
`Elvie has exploited Willow’s patented technology to secure more than $150
`million in funding from investors. Most recently, in 2021, Elvie secured $97 million in its Series
`C funding round. https://techcrunch.com/2021/09/07/womens-health-tech-brand-elvie-tops-up-
`series-c-to-97m/.
`
`ANSWER: Elvie admits that it has secured Series C funding as of 2021. Elvie denies
`
`the remaining allegations of Paragraph 7.
`
`8.
`Elvie has leveraged Willow’s patents to establish itself as a major manufacturer
`and distributor of consumer breast feeding equipment. Willow brings this suit to protect its
`constitutional patent rights against Elvie’s past and continued infringement.
`
`ANSWER: Denied.
`
`JURISDICTION AND VENUE
`
`9.
`This is a civil action for patent infringement arising under the patent laws of the
`United States, 35 U.S.C. §§ 100 et seq. This Court has jurisdiction over the subject matter of this
`action pursuant to 28 U.S.C. §§ 1331 and 1338(a).
`
`ANSWER: Paragraph 9 of the Complaint states legal conclusions to which no
`
`response is required. To the extent a response is required, Elvie admits that Plaintiff purports to
`
`bring a civil action for patent infringement arising under the patent laws of the United States, 35
`
`U.S.C. §§ 100 et seq. Further, Elvie does not contest subject matter jurisdiction over Plaintiff’s
`
`claims under 28 U.S.C. §§ 1331 and 1338(a) for purposes of this this action only. Elvie denies
`
`the remaining allegations of Paragraph 9.
`
`10.
`This Court has personal jurisdiction over Elvie at least because it (1) has
`committed acts of patent infringement and contributed to and induced acts of patent infringement
`by others in this District; (2) regularly did business or solicited business in this District; (3)
`engaged in other persistent courses of conduct and derived substantial revenue by its offering of
`infringing products and services and providing infringing products and services in this District;
`and (4) purposefully established substantial, systematic, and continuous contacts with this
`
`
`
`4
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 5 of 93 PageID #: 2820
`
`
`District and should have reasonably expected to be subject to suit here by its offering of
`infringing products and services and providing infringing products and services in this District.
`
`ANSWER: Paragraph 10 contains legal conclusions and allegations to which no
`
`response is required. To the extent a response is required, Elvie does not contest the Court’s
`
`exercise of personal jurisdiction over it for purposes of this action only. Elvie denies the
`
`remaining allegations of Paragraph 10.
`
`11.
`Elvie has sold their breast pumps and related products within this District via the
`following means:
`
`a. Through its own online store at http://www.elvie.com, customers—including those in
`this District and throughout Texas—can purchase Elvie’s suite of products. Upon
`information and belief, Elvie uses its agents and distribution partners to direct
`infringing products purchased online to customers in this District. Elvie also uses its
`website to engage with and support its customers. For example, Elvie provides
`instructions for using the Elvie Pump through a variety of publicly-available
`resources, including product manuals, answers to common questions, and how-to
`videos. https://www.elvie.com/assets/manuals/elvie_pump_manual_en.pdf;
`https://www.elvie.com/en-us/support/elvie-pump.
`
`b. Elvie has authorized at least nine retailers and distributors to sell its products, as
`described at https://www.elvie.com/en-us/partners/b2b-partners. These partners
`include major retailers such as Walmart, Amazon, Target, Costco, and Best Buy— all
`of which maintain stores, warehouse facilities, and/or distribution centers in this
`District. As detailed below, customers in this District may purchase Elvie products
`from authorized sellers via (1) the authorized seller’s website; or (2) the authorized
`seller’s brick-and-mortar store located within the District:
`
`
`
`5
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 6 of 93 PageID #: 2821
`
`
`Elvie Pump – Hands-Free, Wearable Electric Double Breast Pump, Walmart (last
`visited May 15, 2023), https://www.walmart.com/ip/Elvie-Pump-Hands-Free-
`Wearable-Electric-Double-Breast-Pump/347662224?fulfillmentIntent=In-
`store&adsRedirect=true (showing Elvie Double Electric Breast Pump is available for
`online purchase and also is in stock at Marshall Supercenter in Marshall, TX).
`
`
`
`Elvie Pump – Double Electric Breast Pump, TARGET (last visited May 15, 2023),
`https://www.target.com/p/elvie-pump-double-electric-breast-pump/-/A-
`75662623#lnk=sametab (showing Elvie Double Electric Breast Pump is available for
`online purchase and also is in stock at Target in Longview, TX).
`
`ANSWER: Elvie admits that it has made its products available for sale on its website,
`
`
`
`
`
`6
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 7 of 93 PageID #: 2822
`
`
`as well as other retailer websites including Walmart, Amazon, and Target. Elvie does not contest
`
`personal jurisdiction for purposes of this action only. Elvie denies the remaining allegations of
`
`Paragraph 11.
`
`12.
`Elvie purposefully avails itself of the benefit of conducting business in Texas by
`marketing and selling its products to citizens in the state (including in this District). The United
`States is the largest market in the world for breast pump products, and Texas is the second largest
`state in the United States by population. Given the size of the market and the significant presence
`of retailers, distributors, and other business partners in the state, Elvie has specifically targeted
`Texas as a key market for its products. For example, in August 2022, Elvie’s Chief Commercial
`Officer, Aoife Zakaras-Nally, provided comments to the Houston Chronicle touting the benefits
`and commercial success of the Elvie Pump. https://www.houstonchronicle.com/lifestyle/renew-
`houston/health/article/Breastfeeding-will-never-be-free-But-it-can-be-
`17339050.php?cmpid=gsa-chron-result. Houston is a particularly important market for Elvie,
`given the size and reach of its medical community. See id. (Dr. Stan Spinner, chief medical
`officer of Texas Children’s Hospital based in Houston, describing the benefits of breastfeeding).
`
`ANSWER: Paragraph 12 contains legal conclusions and allegations to which no
`
`response is required. To the extent a response is required, Elvie admits that Plaintiff purports to
`
`present comments by Aoife Zakaras-Nally cited in the Houston Chronicle article from August 1,
`
`2022, titled “Breastfeeding will never be free. But it can be made easier. Here’s how new
`
`technology helps moms.” Elvie denies the remaining allegations of Paragraph 12.
`
`13.
`In addition, on information and belief, Elvie exercises control over its distributors,
`retailers, and other partners that conduct Elvie’s business in Texas. For example, Elvie limits its
`product warranty—ranging in duration from 90 days to two years from the date of purchase—to
`those products purchased directly from Elvie and its authorized sellers. See
`https://www.elvie.com/en-us/warranty (“[T]his limited warranty applies only to original
`purchasers of Elvie Product(s) that were purchased from Chiaro or a Chiaro authorized seller in
`the United States, unless otherwise prohibited by law.”). On its website, Elvie provides
`instructions for anyone interested in becoming an authorized seller of Elvie products.
`https://www.elvie.com/en-us/partners/b2b-partners.
`
`ANSWER: Paragraph 12 contains legal conclusions and allegations to which no
`
`response is required. To the extent a response is required, Elvie admits that Plaintiff purports to
`
`present an incomplete selection or summary of text from Elvie’s webpages, but the actual and
`
`complete disclosure of the webpages speaks for themselves and are controlling. Elvie denies the
`
`
`
`7
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 8 of 93 PageID #: 2823
`
`
`remaining allegations of Paragraph 13.
`
`14.
`Elvie, directly and through subsidiaries or intermediaries (including distributors,
`retailers, and others), has purposefully and voluntarily placed its infringing products into this
`District and into the stream of commerce with the intention and expectation that the infringing
`products will be purchased for use in Texas and in this District. Elvie has imported, offered for
`sale and sold, and continues to import, offer for sale and sell, infringing products for delivery and
`use in this District. Thus, Elvie has intentionally targeted Texas, and this District, for its business
`activities, and has purposefully availed itself of the benefits of conducting business in Texas such
`that it should reasonably anticipate being subject to its laws and the jurisdiction of its courts.
`
`ANSWER: Paragraph 14 contains legal conclusions and allegations to which no
`
`response is required. To the extent a response is required, Elvie does not contest the Court’s
`
`exercise of personal jurisdiction over it for purposes of this action only. Elvie denies the
`
`remaining allegations of Paragraph 14.
`
`15.
`Venue is proper in this District under at least 28 U.S.C. §§ 1391(b), (c) and/or
`1400(b). Venue is proper with respect to Elvie because it is a foreign entity that has committed
`acts of infringement in this District, as detailed throughout this Complaint. Elvie has committed
`and continues to commit acts of patent infringement in this District, by, among other things,
`directly and/or indirectly making, using, selling, offering to sell, or importing products that
`infringe one or more claims of the Patents-in-Suit.
`
`ANSWER: Paragraph 15 contains legal conclusions and allegations to which no
`
`response is required. To the extent a response is required, Elvie does not contest venue for
`
`purposes of this action only. Elvie denies the remaining allegations of Paragraph 15.
`
`THE ASSERTED PATENTS
`
`16.
`This action involves seven asserted patents: U.S. Patent No. 10,398,816 (“the
`’816 Patent”), U.S. Patent No. 10,434,228 (“the ’228 Patent”), U.S. Patent No. 10,625,005 (“the
`’005 Patent”), U.S. Patent No. 10,722,624 (“the ’624 Patent”), U.S. Patent No. 11,185,619 (“the
`’619 Patent”), U.S. Design Patent No. D832,995 (“the ’D995 Patent”), U.S. Design Patent No.
`D977,625 (“the ’D625 Patent”), and U.S. Patent No. 10,688,229 (“the ’229 Patent”)
`(collectively, the “Asserted Patents”).
`
`ANSWER: Elvie denies that this action purportedly involves seven asserted patents,
`
`as Willow added an eighth patent in its First Amended Complaint: U.S. Patent No. 10,398,816
`
`(“the ’816 Patent”); U.S. Patent No. 10,434,228 (“the ’228 Patent”); U.S. Patent No. 10,625,005
`
`
`
`8
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 9 of 93 PageID #: 2824
`
`
`(“the ’005 Patent”); U.S. Patent No. 10,722,624 (“the ’624 Patent”); U.S. Patent No. 11,185,619
`
`(“the ’619 Patent”); U.S. Design Patent No. D832,995 (“the ’D995 Patent”); U.S. Design Patent
`
`No. D977,625 (“the ’D625 Patent”); and U.S. Patent No. 10,688,229 (“the ’229 patent”)
`
`(collectively, the “Asserted Patents”). Elvie denies the remaining allegations of Paragraph 16.
`
`17.
`The Asserted Patents recognized multiple problems with then-existing systems
`and methods for pumping milk. For example, as the ’624 Patent explains, “[a]lthough a variety
`of breast pumps are available, most are awkward and cumbersome, requiring many parts and
`assemblies and being difficult to transport.” Exhibit 1 at 1:30-32. Manual breast pumps can be
`“onerous” and “painful” to use. Id. at 1:33-34. Some of the available powered breast pumps
`“require an AC power source to plug into during use,” while other available battery-powered
`pumps “draw down the battery power fairly rapidly as the motorized pump continuously operates
`to maintain suction during the milk extraction process.” Id. at 1:36-38. Existing pumps had the
`further disadvantages of being “clearly visible to an observer when the mother is using it” and
`“expos[ing] the breast of the mother during use.” Id. at 1:38-41. As the ’624 Patent explains,
`‘[t]here is a continuing need for a small, portable…wearable breast pump system” that would not
`expose the breast of the user, and could be “invisible or nearly unnoticeable when worn.” Id. at
`1:42-46.
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’624 patent, but the actual and complete disclosure of the ’624 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 17.
`
`18.
`To address these deficiencies in the art, the Asserted Patents provide a wearable,
`inconspicuous, convenient pump. In various embodiments, “the system defines a natural breast
`profile” which would “fit comfortably and conveniently into a bra of a user and to present a
`natural look.” Exhibit 1 at 2:5-8. The pumping devices and storage containers of the inventions
`can be “sized and shaped to be received within a user’s bra.” Id. at 2:24-26. “Pumping of milk
`from a breast can occur without creating a change in a total mass and volume of the breast, pump
`device and storage container. The storage container can be one or more of flexible, or position
`around the breast.” Id. at 2:26-30.
`
`ANSWER:
`
`Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’624 patent, but the actual and complete disclosure of the ’624 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 18.
`
`U.S. Patent No. 10,398,816
`
`19.
`On September 3, 2019, the USPTO duly and lawfully issued the ’816 Patent,
`entitled “Breast pump system with flange.” A true and correct copy of the ’816 Patent is attached
`
`
`
`9
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 10 of 93 PageID #: 2825
`
`
`as Exhibit 2. By assignment, duly recorded with the USPTO, Willow owns all substantial rights
`to the ’816 Patent, including the right to sue and recover damages for all infringement.
`
`ANSWER: Elvie admits that on its face, the ’812 patent titled “Breast pump system
`
`with flange” issued on September 3, 2019. Elvie lacks sufficient knowledge and information to
`
`form a belief as to the truth of the remaining allegations of Paragraph 19 as pled and denies those
`
`allegations on that basis.
`
`20.
`The ’816 Patent generally relates to a breast pumping system where milk is
`expressed from the breast under suction, and the milk is moved by the pumping mechanism to a
`collection container using pressure and all responsive to a controller. See id. at Abstract. The
`’816 Patent further provides for a portion of the system that contacts the skin, called the flange,
`designed as a “lower profile component” as compared to the prior art. Id. at 20:10-11.
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’816 patent, but the actual and complete disclosure of the ’816 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 20 that are contrary
`
`to the actual and complete disclosure of the ’816 patent.
`
`21.
`The ’816 Patent recognized a problem with then-existing systems and methods for
`pumping milk. As the ’816 Patent explains, “[a]lthough a variety of breast pumps are available,
`most are awkward and cumbersome, requiring many parts and assemblies and being difficult to
`transport.” Exhibit 2 at 1:23-25. Manual breast pumps can be “onerous” and “painful” to use. Id.
`at 1:25-27. Some of the available powered breast pumps “require an AC power source to plug
`into during use,” while other available battery-powered pumps “draw down the battery power
`fairly rapidly as the motorized pump continuously operates to maintain suction during the milk
`extraction process.” Id. at 1:27-31. Existing pumps had the further disadvantages of being
`“clearly visible to an observer when the mother is using it” and “expos[ing] the breast of the
`mother during use.” Id. at 1:31-34. In addition, “[m]any existing breast pump systems can cause
`considerable discomfort to the user over time. One cause of such discomfort is chafing of the
`nipple against the nipple flange/housing as the nipple stretches and contracts during the pumping
`session. There is a continuing need for a breast pump system that is more comfortable to the
`user, even over repeated pumping sessions.” Id. at 1:49-55.
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’816 patent, but the actual and complete disclosure of the ’816 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 21.
`
`22.
`
`The ’816 Patent describes specific improvements to then-existing systems and
`
`
`
`10
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 11 of 93 PageID #: 2826
`
`
`methods for pumping milk. For example, in various embodiments, “the system defines a natural
`breast profile” which would “fit comfortably and conveniently into a bra of a user and to present
`a natural look.” Id. at 2:14-18. In addition, the claimed system maintains “at least a latch suction
`level at all times,” which results in a “more secure and persistent seal to the breast and
`significantly reduce[d] potential for leaks.” Id. at 20:3-6. This has several benefits to the user,
`including “less friction on the side of the nipple against the flange wall, thereby greatly reducing
`the risk of irritation, skin damage, pain, swelling, etc.” Id. at 19:64-67. Additionally, because
`“the nipple travels less, this allows for the skin attachment member/flange to be designed as a
`lower profile component, as its length can be shorter…” Id. at 20:9-11. This benefit in turn limits
`the “overall amount of protrusion of the system from the breast to less than that in the prior
`art…” Id. at 20: 13-15.
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’816 patent, but the actual and complete disclosure of the ’816 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 22.
`
`23.
`As an example of the improvements in the ’816 Patent over the prior art, Figure 8
`provides a flange of an embodiment of the invention, and Figure 9 provides an exemplary prior
`art flange:
`
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`
`
`of figures of the ’816 patent, but the actual and complete disclosure of the ’816 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 23 that are contrary
`
`to the actual and complete disclosure of the ’816 patent.
`
`24.
`The claims of the ’816 Patent capture specific technological improvements. For
`example, Claim 1 of the ’816 Patent provides for “a flange attached to the breast pump shell and
`
`
`
`11
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 12 of 93 PageID #: 2827
`
`
`configured to receive the breast” with a “rigid nipple receiving portion.” Id., Claim 1, 50:56-61.
`Claim 6 of the ’816 Patent adds a limitation to a “control loop [] used to adjust a speed of the
`compression member to vary or maintain the suction pressure.” Id., Claim 6, 51:12-16.
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’816 patent, but the actual and complete disclosure of the ’816 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 24.
`
`25.
`The claimed improvements of the ’816 Patent, including the ability to maintain
`suction and the corresponding characteristics of the claimed flange, were not routine,
`conventional, or well-known. These improvements were advantageous and inventive over the
`prior art systems that were cumbersome, difficult to transport, inefficient and/or inconvenient to
`power, and difficult to use discreetly. The ’816 Patent recognized the unconventional and
`advantageous nature of the claimed small, portable, self-powered, energy efficient, wearable
`breast pump system. Id. at 1:35-49. As the ’816 Patent explains, these improvements were
`advantageous and inventive over the prior art systems with less comfortable skin contact
`portions. The ’816 Patent recognized the unconventional and advantageous nature of achieving a
`shorter protrusion of the system from the breast, by providing improved suction and, in turn, the
`claimed flange. The improved systems and methods of the ’816 Patent, recited in the claims,
`provide technological benefits over the prior art.
`
`ANSWER: Denied.
`
`U.S. Patent No. 10,434,228
`
`26.
`On October 8, 2019, the USPTO duly and lawfully issued the ’228 Patent, entitled
`“Breast pump system and methods.” A true and correct copy of the ’228 Patent is attached as
`Exhibit 4. By assignment, duly recorded with the USPTO, Willow owns all substantial rights to
`the ’228 Patent, including the right to sue and recover damages for all infringement.
`
`ANSWER: Elvie admits that on its face, the ’228 patent titled “Breast pump system
`
`and methods” issued on October 8, 2019. Elvie lacks sufficient knowledge and information to
`
`form a belief as to the truth of the remaining allegations of Paragraph 26 as pled and denies those
`
`allegations on that basis.
`
`27.
`The ’228 Patent generally relates to a breast pumping system where milk is
`expressed from the breast under suction, and the milk is moved by the pumping mechanism to a
`collection container using pressure. See id. at Abstract.
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete
`
`summaries of the text of the ’228 patent, but the actual and complete disclosure of the ’228
`
`
`
`12
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 13 of 93 PageID #: 2828
`
`
`patent speaks for itself and is controlling. Elvie denies the remaining allegations of Paragraph 27
`
`that are contrary to the actual and complete disclosure of the ’228 patent.
`
`28.
`The ’228 Patent recognized a problem with then-existing systems and methods for
`pumping milk. As the ’228 Patent explains, “[w]hen a user has completed the pumping phase of
`extracting milk…, it is useful and efficient to purge as much milk that remains…from the tubing
`[] and into the milk collection container [].” Id. at 41:8-11.
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’228 patent, but the actual and complete disclosure of the ’228 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 28.
`
`29.
`The ’228 Patent describes specific improvements to then-existing systems and
`methods for pumping milk. In particular, the ’228 Patent provides systems with numerous
`methods for avoiding loss of milk after extraction from the breast. For example, Figure 38
`illustrates events that may be carried out to perform a purge. Id. at 14:37-39. Figures 39A and
`39B further provide additional arrangements that may be provided to help prevent loss of milk
`out of the system.
`
`
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text and figures of the ’228 patent, but the actual and complete disclosure of the ’228 patent
`
`speaks for itself and is controlling. Elvie denies the remaining allegations of Paragraph 29.
`
`30.
`The claims of the ’228 Patent capture specific technological improvements. For
`example, Claim 1 provides an automated method of pumping milk, “wherein the milk is pumped
`from the breast to the collection container upwardly through the milk flow path relative to a
`bottom of the breast contacting structure.” Id. at Claim 1, 50:44-47.
`
`
`
`13
`
`

`

`Case 2:23-cv-00229-JRG Document 60 Filed 04/15/24 Page 14 of 93 PageID #: 2829
`
`
`ANSWER: Elvie admits that Plaintiff purports to present certain incomplete selections
`
`of text of the ’228 patent, but the actual and complete disclosure of the ’228 patent speaks for
`
`itself and is controlling. Elvie denies the remaining allegations of Paragraph 30.
`
`31.
`The claimed improvements of the ’228 Patent were not routine, conventional, or
`well-known. As the ’228 Patent explains, these improvements were advantageous and inventive
`over the prior art techniques without the provided methods of avoiding milk loss. The ’228
`Patent recognized the unconventional and advantageous nature of directing the flow of milk
`upward. The improved systems and methods of the ’228 Patent, recited in the claims, provide
`technological benefits over the prior art.
`
`ANSWER: Denied.
`
`U.S. Patent No. 10,625,005
`
`32.
`On April 21, 2020, the USPTO duly and lawfully issued the ’005 Patent, entitled
`“Breast pump assembly with remote interface.” A true and correct copy of the ’005 Patent is
`attached as Exhibit 5. By assignment, duly recorded with the USPTO, Willow owns all
`substantial rights to the ’005 Patent, including the right to sue and recover damages for all
`infringement.